JMP Securities Upgrades Sarepta Therapeutic (SRPT) to Market Outperform
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $18.39 --0%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 2 | New: 10
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 2 | New: 10
Join SI Premium – FREE
JMP Securities upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Market Perform to Market Outperform with a price target of $54.00.
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $24.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies on Sarepta Therapeutics (SRPT): 'The risk/reward seems favorable'
- CFRA Double Upgrades Everpure (P) to Buy
- Sarepta to present Phase 4 Duchenne drug data at neuromuscular meeting
Create E-mail Alert Related Categories
UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
